Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-06-04 | Dr. Barry J. SimonChief Corporate Affairs Officer & Director | -23,03k | 165,31k | Automatic Disposition | 7,18 | 2,83M | -0,81% |
| 2026-03-31 | California Capital Equity, LLCSocietà | 4,61M | 25,00M | Derivative Exercise and Retained Stock | 5,43 | 259,00M | 1,81% |
| 2026-02-24 | Dr. Barry J. SimonChief Corporate Affairs Officer & Director | -75,00k | 900,79k | Automatic Disposition | 12,01 | 2,85M | -2,56% |
| 2026-02-23 | Ms. Christobel E. SeleckyIndependent Director | -25,00k | 175,50k | Derivative Exercise and Sale | 2,98 - 10,00 | 0,00 | - |
| 2026-02-22 | Ms. Regan J. LauerCAO | 2,39k | 0,00 | Derivative Exercise and Retained Stock | - | 115,88k | 2,11% |
| 2026-02-22 | Ms. Regan J. LauerCAO | -1,67k | 14,56k | Derivative Exercise and Sale | 8,70 | 115,88k | - |
| 2026-02-22 | Mr. Richard Gerald AdcockPresident, CEO & Director | 74,88k | 0,00 | Derivative Exercise and Retained Stock | - | 560,34k | 15,42% |
| 2026-02-22 | Mr. Richard Gerald AdcockPresident, CEO & Director | -77,56k | 674,77k | Derivative Exercise and Sale | 8,70 | 560,34k | - |
| 2026-02-22 | Mr. David C. SachsCFO | 19,97k | 0,00 | Derivative Exercise and Retained Stock | - | 300,14k | 7,13% |
| 2026-02-22 | Mr. David C. SachsCFO | -20,68k | 179,93k | Derivative Exercise and Sale | 8,70 | 300,14k | - |
| 2026-02-22 | Dr. Patrick Soon-ShiongFounder, Executive Chairman and Global Chief Scientific & Medical Officer | 56,16k | 0,00 | Derivative Exercise and Retained Stock | - | 291,46M | 0,02% |
| 2026-02-22 | Dr. Patrick Soon-ShiongFounder, Executive Chairman and Global Chief Scientific & Medical Officer | -58,17k | 506,08k | Derivative Exercise and Sale | 8,70 | 291,46M | - |
| 2026-02-22 | Dr. Barry J. SimonChief Corporate Affairs Officer & Director | -15,24k | 146,89k | Derivative Exercise and Sale | 8,70 - 10,25 | 2,93M | - |
| 2026-02-20 | Dr. Barry J. SimonChief Corporate Affairs Officer & Director | -165,78k | 1,69M | Automatic Disposition | 9,25 - 10,25 | 2,93M | -5,36% |
| 2026-02-10 | Dr. Patrick Soon-ShiongFounder, Executive Chairman and Global Chief Scientific & Medical Officer | 155,56k | 0,00 | Derivative Exercise and Retained Stock | - | 291,41M | 0,05% |
| 2026-02-10 | Dr. Patrick Soon-ShiongFounder, Executive Chairman and Global Chief Scientific & Medical Officer | -118,56k | 821,62k | Derivative Exercise and Sale | 6,93 | 291,41M | - |
| 2026-02-10 | Mr. David C. SachsCFO | 39,59k | 0,00 | Derivative Exercise and Retained Stock | - | 280,18k | 16,46% |
| 2026-02-10 | Mr. David C. SachsCFO | -42,64k | 295,52k | Derivative Exercise and Sale | 6,93 | 280,18k | - |
| 2026-02-10 | Ms. Regan J. LauerCAO | 3,23k | 0,00 | Derivative Exercise and Retained Stock | - | 113,48k | 2,92% |
| 2026-02-10 | Ms. Regan J. LauerCAO | -2,26k | 15,64k | Derivative Exercise and Sale | 6,93 | 113,48k | - |
| 2026-02-10 | Mr. Richard Gerald AdcockPresident, CEO & Director | 134,07k | 0,00 | Derivative Exercise and Retained Stock | - | 485,47k | 38,16% |
| 2026-02-10 | Mr. Richard Gerald AdcockPresident, CEO & Director | -140,05k | 970,53k | Derivative Exercise and Sale | 6,93 | 485,47k | - |
| 2026-01-20 | Dr. Barry J. SimonChief Corporate Affairs Officer & Director | -151,97k | 1,09M | Automatic Disposition | 6,54 - 7,88 | 3,09M | -4,69% |
| 2026-01-16 | Ms. Christobel E. SeleckyIndependent Director | -75,00k | 214,15k | Derivative Exercise and Sale | 2,98 - 7,51 | 0,00 | - |
| 2025-12-31 | Mr. David C. SachsCFO | 14,96k | 0,00 | Derivative Exercise and Retained Stock | - | 240,58k | 6,63% |
| 2025-12-31 | Mr. David C. SachsCFO | -15,44k | 30,56k | Derivative Exercise and Sale | 1,98 | 240,58k | - |
| 2025-12-31 | Mr. Richard Gerald AdcockPresident, CEO & Director | 16,97k | 0,00 | Derivative Exercise and Retained Stock | - | 351,39k | 5,08% |
| 2025-12-31 | Mr. Richard Gerald AdcockPresident, CEO & Director | -17,51k | 34,67k | Derivative Exercise and Sale | 1,98 | 351,39k | - |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
